DMAA

Drugs Made In America Acquisition Corp.

NasdaqGM · USD

Analyze chart

$10.76+$0.00 +0.00%At close 4:00 PM ET · Sep 4, 2026

After hours — awaiting data

DMAA Community →

Key statistics

Market cap$261.22M

P/E ratio59.78

EPS0.18

Beta—

Day high$10.76

Day low$10.76

52-week high$10.77

52-week low$10.23

Volume29.71K

Avg volume25.42K

Dividend yield—

About Drugs Made In America Acquisition Corp.

Financial ServicesShell CompaniesNasdaqGM

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Headquarters: New York, NY, United States

What's your take on DMAA?

Be the first to share your outlook and start the conversation with other investors in the DMAA community.

Share your take